NDC codes

404917 NDC codes with hospital pricing data in the network.

• NDC 00078-0734-61 — Canakinumab 150 mg/mL injectionAI (251 hospitals, 304–340 samples)
• NDC 00703-3333-01 — Octreotide acetate injection, 200 mcg per mLAI (101 hospitals, 34–340 samples)
• NDC 59148-0045-80 — Aripiprazole extended-release injection syringeAI (353 hospitals, 313–340 samples)
• NDC 00143-9875-01 — Amiodarone hydrochloride injection 150 mgAI (574 hospitals, 133–340 samples)
• NDC 00703-3301-04 — Octreotide acetate 50 mcg/mL injectionAI (223 hospitals, 34–340 samples)
• NDC 23155-0685-31 — Octreotide acetate 200 mcg/mL injectionAI (193 hospitals, 34–340 samples)
• NDC 6933913602 — DIAZEPAM 5 MG/ML INJECTION SYRINGEAI (29 hospitals, 34–340 samples)
• NDC 6933913603 — DIAZEPAM 5 MG/ML INJECTION SYRINGEAI (57 hospitals, 34–340 samples)
• NDC 6933913632 — DIAZEPAM 5 MG/ML INJECTION SYRINGEAI (26 hospitals, 34–340 samples)
• NDC 6937496502 — DIAZEPAM 5 MG/ML INJECTION SYRINGEAI (45 hospitals, 34–340 samples)
• NDC 23155-0869-31 — Arsenic trioxide intravenous solution, 1 mg/mLAI (65 hospitals, 304–340 samples)
• NDC 63323-0377-00 — Octreotide acetate 500 mcg/mL injectionAI (347 hospitals, 34–340 samples)
• NDC 00069-2465-01 — Respiratory syncytial virus (RSV) vaccineAI (68 hospitals, 34–340 samples)
• NDC 71288-0026-75 — VANCOMYCIN 10 GRAM INTRAVENOUS SOLUTIONAI (141 hospitals, 34–340 samples)
• NDC 00409-0528-13 — Levofloxacin 250 mg IV piggyback in dextroseAI (62 hospitals, 34–340 samples)
• NDC 09890-0971-00 — CEFAZOLIN SODIUM NACL 2-0.9 GM-% IV SOLN (11 hospitals, 34–340 samples)
• NDC 09990-3188-50 — CEFAZOLIN (50 MG/ML) IN D5W PEDS/NICU (11 hospitals, 34–340 samples)
• NDC 00069-0310-20 — Cefazolin in dextrose for pediatric and NICU useAI (13 hospitals, 34–340 samples)
• NDC 09999-9031-89 — CEFAZOLIN (50 MG/ML) IN NS PEDS/NICU (11 hospitals, 34–340 samples)
• NDC 09999-0183-15 — CEFAZOLIN 1000 MG IN 500 ML NS IRRIGATION BOTTLE SIMPLE (11 hospitals, 34–340 samples)
• NDC 09920-0003-21 — MIDAZOLAM PEDIATRIC DRIP </= 20 KG (9 hospitals, 214–340 samples)
• NDC 00992-0003-54 — MIDAZOLAM PEDIATRIC STATUS EPILEPTICUS DRIP (9 hospitals, 214–340 samples)
• NDC 09920-0003-20 — MIDAZOLAM PEDIATRIC DRIP </= 20 KG (9 hospitals, 214–340 samples)
• NDC 09920-0003-19 — MIDAZOLAM PEDIATRIC DRIP LOW (9 hospitals, 214–340 samples)
• NDC 09991-3405-00 — Enoxaparin 20 mg/mL injection syringeAI (21 hospitals, 34–340 samples)
• NDC 71288040402A — HEPARIN SODIUM 10000UNIT/ML I (2 hospitals, 277–340 samples)
• NDC 71288-0107-20 — Bleomycin sulfate injection, 30-unit vialAI (385 hospitals, 105–339 samples)
• NDC 409665106 — Potassium chloride liquid, 10 mL vialAI (157 hospitals, 105–339 samples)
• NDC 00054-0222-25 — Quetiapine oral suspensionAI (35 hospitals, 276–339 samples)
• NDC 00187-0993-95 — Acyclovir 5% ointment, 30 gram tubeAI (110 hospitals, 276–339 samples)
• NDC 24200-0562-03 — INJECTION, MIDAZOLAM HYDROCHLORIDE, PER 1 MG (1 hospital, 258–339 samples)
• NDC 99999-1001-21 — clarithromycin 125 mg/5 mL Susr 1 mL (3 hospitals, 258–339 samples)
• NDC 781311395 — Piperacillin-tazobactam 3.375 gram IV antibioticAI (102 hospitals, 185–338 samples)
• NDC 00006-4047-02 — Rotavirus vaccine oral suspensionAI (77 hospitals, 320–338 samples)
• NDC 00904-6914-61 — Methylprednisolone 4 mg tabletsAI (317 hospitals, 220–337 samples)
• NDC 65219-0429-50 — Argatroban 1 mg/mL in saline IV solutionAI (207 hospitals, 318–336 samples)
• NDC 00093-5852-01 — Escitalopram 20 mg tabletAI (23 hospitals, 309–336 samples)
• NDC 00378-9055-93 — Lidocaine 5% patchAI (132 hospitals, 300–336 samples)
• NDC 4420630001 — Rho(D) immune globulin injection syringeAI (47 hospitals, 57–336 samples)
• NDC 4420630010 — Rho(D) immune globulin injection, 300 mcg syringeAI (42 hospitals, 57–336 samples)
• NDC 4420630090 — Rho(D) immune globulin injection, 300 mcg syringeAI (30 hospitals, 57–336 samples)
• NDC 70095-0031-01 — Desmopressin injectionAI (158 hospitals, 56–335 samples)
• NDC 00409-2337-25 — Deferoxamine 2 gram injection solutionAI (293 hospitals, 254–335 samples)
• NDC 59762-4537-02 — Medroxyprogesterone 150 mg/mL injectionAI (126 hospitals, 101–335 samples)
• NDC 338350341 — Cefazolin in dextrose IV bagAI (89 hospitals, 173–335 samples)
• NDC 70860-0125-41 — Azithromycin 500 mg vialAI (186 hospitals, 47–335 samples)
• NDC 74368303 — Leuprolide 4-month injection kitAI (130 hospitals, 290–335 samples)
• NDC 70121-1467-02 — Medroxyprogesterone acetate 150 mg/mL injectionAI (108 hospitals, 200–335 samples)
• NDC 70710-1359-01 — Lacosamide intravenous injection, 200 mgAI (372 hospitals, 82–334 samples)
• NDC 55513-0123-01 — Tezspire 210 mg/1.91 mL subcutaneous autoinjectorAI (160 hospitals, 226–334 samples)